The American Journal of Human GeneticsGenetic & Genomic MedicinePeer-reviewed journal article
Genetic risk estimates for offspring of patients with Stargardt disease
Stéphanie S. CornelisiD, Esmee H. RunhartiD, Miriam BauwensiD, Zelia CorradiiD, Elfride De BaereiD, Susanne RoosingiD, Lonneke Haer‐WigmaniD, Claire‐Marie DhaenensiD, Anneke T. Vulto‐van SilfhoutiD, Frans P.M. CremersiD
Abstract
BACKGROUNDGenetic counseling in autosomal recessive Stargardt disease (STGD1) is complicated because of unknown frequencies of pathogenic ABCA4 alleles across populations, variable and unknown severity of ABCA4 alleles, and incomplete penetrance. METHODSIn this cross-sectional study, published ABCA4 variants were categorized by severity based on previous functional and clinical studies and current statistical comparisons of their frequencies in patients versus the general population, their observed versus expected homozygous occurrence in patients, and their occurrence in combination with established mild alleles in patients. The sum allele frequencies of these severity categories were used to estimate inheritance risks for offspring of STGD1 patients and carriers of pathogenic ABCA4 variants. RESULTSThe risk for offspring of a STGD1 patient with the severe|severe genotype or a severe|mild with complete penetrance genotype to develop STGD1 at some moment in life was estimated at 2.8-3.1% (1 in 35-32 individuals) and 1.6-1.8% (1 in 62-57 individuals), respectively. The risk to develop STGD1 in childhood was estimated to be 2 to 4-fold lower: 0.7-0.8% (1 in 148-124) and 0.3-0.4% (1 in 295-248), respectively. For offspring of an unaffected ABCA4 variant carrier from a STGD1 family who carries one severe or one mild ABCA4 variant with complete penetrance, the risk to develop STGD1 throughout life is 1.4-1.6% (1 in 71-64) and 0.19-0.21% (1 in 516-487), respectively. CONCLUSIONWe propose a genotype-based personalized counseling approach to appreciate the large differences in inheritance risk between individuals. We advocate considering the lower risk of early-onset STGD1 compared with the total STGD1 risk.
- Citations
- 55
- FWCI
- 4.73
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Compendium of clinical variant classification for 2,247 unique ABCA4 variants to improve genetic medicine access for Stargardt Disease
Stéphanie S. Cornelis, Miriam Bauwens, … Frans P.M. Cremers·medRxiv·Apr 24, 2023
- Resolving the dark matter of ABCA4 for 1,054 Stargardt disease probands through integrated genomics and transcriptomics
Mubeen Khan, Stéphanie S. Cornelis, … Frans P.M. Cremers·Genetics in MedicinePeer-reviewed·Apr 19, 2020
- Heterozygous ATP-binding Cassette Transporter G5 Gene Deficiency and Risk of Coronary Artery Disease
Akihiro Nomura, Connor A. Emdin, … Sekar Kathiresan·Circulation Genomic and Precision MedicinePeer-reviewed·Aug 30, 2020
- Pathogenic impact of ABCA4 missense variants in the structurally uncharacterized ECD1 region: implications for Stargardt disease.
Nadee N. J. Matarage Don, Subhasis B. Biswas, Esther E. Biswas·bioRxiv·Jul 1, 2026
- Polygenic Parkinson's disease genetic risk score as risk modifier of parkinsonism in Gaucher disease
Cornelis Blauwendraat, Nahid Tayebi, … Ellen Sidransky·Movement DisordersPeer-reviewed·Mar 3, 2023
- The landscape of autosomal-recessive pathogenic variants in European populations reveals phenotype-specific effects
Hila Fridman, Helger G. Yntema, … Han G. Brunner·The American Journal of Human GeneticsPeer-reviewed·Mar 18, 2021